Press Releases
 
Trichomoniasis Drugs Market – Current Scenario and Future Growth Analysis by 2025

, 16 May 2018 -- Trichomoniasis Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Trichomoniasis is a ######## transmitted disease (STD) which is caused by the flagellated protozoan parasite passed from one person to another during ###; the parasite usually transmits from a vagina to a penis or from penis to a vagina, and some time, from a vagina to another vagina. Men and women are suffering from trichomoniasis globally. The commonly infected part of the body in women is the lower genital tract (vulva, cervix, vagina, or urethra), while that in men is the inside of the penis (urethra).

Trichomoniasis can be asymptomatic or can cause vaginitis, urethritis, or occasionally epididymitis, cystitis, or prostatitis. Burning after urination or ejaculation, itching, redness or soreness of genitals, itching or irritation inside the penis, discomfort while urinating in women, discharge from the penis, dyspareunia, yellow-green, frothy vaginal discharge with soreness of the vulva and perineum, dysuria, urethritis, and purulent area are some of the common symptoms of trichomoniasis. Epididymitis and prostatitis are the major complications of trichomoniasis.

Obtain Report Details @ https://www.transparencymarketresearch.com/trichomoniasis-drugs-market.html

Nucleic acid amplification tests (NAAT), direct fluorescent tests, direct microscopic examination of vaginal secretions, and immunochromographic are the common tests recommended by health care specialists for the diagnosis of trichomoniasis. Trichomoniasis is suspected in men with urethritis, in women with vaginitis, or in their ###### partners. According to a report published by the WHO, trichomoniasis cases are higher in number than chlamydia or gonorrhea cases every year. Trichomoniasis can be treated with metronidazole or tinidazole. Tinidazole is an anti-parasitic drug, while metronidazole is an antibiotic and antiprotozoal medication used for the treatment of trichomoniasis. Metronidazole is available in the market under brand name, Flagyl.

The global trichomoniasis drugs market is expanding significantly due to increase in the incidences of trichomoniasis. Rise in cases of unprotected ### has contributed to the spread of the disease. Low voluntary screening rate for the disease is a major restraint of the market. Awareness about trichomoniasis diagnostic tests is poor in the countries in Africa. Therefore, companies are facing challenges with regard to market penetration in the region. Moreover, several low and middle-income countries depend on government grants for the provision of rapid diagnostic tests in the event of an epidemic. Thus, direct reach to customers is limited in these countries. These factors hamper the growth of the trichomoniasis drugs market in the region.

Download Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=34040

The global trichomoniasis drugs market can be segmented based on drug type, distribution channel, and region. In terms of drug type, the market can be categorized into metronidazole and tinidazole. In terms of distribution channel, the global trichomoniasis drugs market can be classified into hospital pharmacies, retail pharmacies, and online pharmacies. Based on revenue, the hospital pharmacies segment constituted a significant share of the trichomoniasis drugs market in 2016.

In terms of region, the global trichomoniasis drugs market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is the leading market for trichomoniasis drugs. In terms of revenue, the U.S. accounts for the dominant share of the trichomoniasis drugs market in North America. The market in Europe is expanding rapidly due to an increase in the number of patients, especially in the U.K. and Germany.

The markets in Asia Pacific and Latin America are projected to expand significantly in the near future. Developing economies such as China and Japan are anticipated to contribute to the growth of the market in the region between 2017 and 2025 due to better health care infrastructure, economic growth, increase in the number of insurance payers, growth of the private health care sector, and increase in awareness among people.

Enquiry for discount on this report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=34040

Key players operating in the global trichomoniasis drugs market are Pfizer, Inc., Lupin Ltd., Teva Pharmaceutical Industries Ltd., Zydus Pharmaceuticals (USA) Inc., Valeant Pharmaceuticals International, Inc., Mission Pharma, Unique Pharmaceutical Laboratories Ltd., and Edenbridge Pharmaceuticals among others.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email:
Website: http://www.transparencymarketresearch.com

# # #


Submitted by hawer on Wednesday, 16 May 2018 at 8:32 PM
Category: Health Care & Medical
 
Related News

Time to Rebalance Your Soul Using Healing Crystals
Saturday, 21 Jul 2018

Pain Management Improved With Sleep Aid Supplements
Saturday, 21 Jul 2018

Solve.Care Welcomes Vincent Everts as New Member of the Company’s Advisory Board
Saturday, 21 Jul 2018

Care.Card UX Contest Gathered more than 200 individuals and organizations to participate
Saturday, 21 Jul 2018

Thinking to get Thyromine?
Friday, 20 Jul 2018

Related Events

Mastering Clinical Challenges and Emerging Therapies in IBD
Saturday, 21 Jul 2018

Priority U LIVE
Sunday, 22 Jul 2018

Update in Orthpaedic Surgery Conference July 22-26, 2018 Grand Wailea, Maui
Sunday, 22 Jul 2018

Echocardiographic Symposium at Vail
Monday, 23 Jul 2018

Imaging in Hawaii
Monday, 23 Jul 2018

Latest News

Piano Debiti
Sunday, 22 Jul 2018

Lion Group Holdings Limited
Sunday, 22 Jul 2018

A Leader in the Jewellery Industry in the United Kingdom
Sunday, 22 Jul 2018

Nursing English
Sunday, 22 Jul 2018

The Numerous Benefits Of Personalized Dog Tags
Sunday, 22 Jul 2018

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2018
Today is Sunday, 22 July 2018

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • Palo Alto Networks: UTD NGFW - Pune 20 July 2018
  • Townlands Carnival 2018 - Music, Art And Carnival
  • Mastering Clinical Challenges and Emerging Therapies in IBD
  • Priority U LIVE
  • Update in Orthpaedic Surgery Conference July 22-26, 2018 Grand Wailea, Maui

  • Latest Jobs
    Sorry, there are currently no entries posted here.